Literature DB >> 12857984

Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.

Arnold I Levinson1, Yi Zheng, Glen Gaulton, Decheng Song, Jonni Moore, C Hank Pletcher.   

Abstract

The thymus has been considered to play an important role in the pathogenesis of myasthenia gravis (MG), an autoimmune disease characterized by skeletal muscle weakness. However, the pathogenic role of the thymus still remains a mystery. The neuromuscular type of acetylcholine receptor (AChR) was the first self-protein associated with a defined autoimmune disease that was found to be expressed by thymic stromal populations. The studies described herein represent our efforts to determine how this "promiscuous" autoantigen expression may be involved in the immunopathogenesis of MG. We review our work, characterizating the expression of the alpha subunit of AChR (AChRalpha) in the thymus, and advance a new hypothesis that examines the intrathymic expression of this autoantigen in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857984     DOI: 10.1385/IR:27:2-3:399

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  63 in total

Review 1.  "Promiscuous" expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?

Authors:  L Klein; B Kyewski
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

2.  Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations.

Authors:  G Genkins; A E Papatestas; S H Horowitz; P Kornfield
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

3.  Acetylcholine receptor alpha subunit mRNA expression in human thymus: augmented expression in myasthenia gravis and upregulation by interferon-gamma.

Authors:  Y Zheng; L M Wheatley; T Liu; A I Levinson
Journal:  Clin Immunol       Date:  1999-05       Impact factor: 3.969

4.  Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.

Authors:  Y Zhang; M Schluep; S Frutiger; G J Hughes; M Jeannet; A Steck; T Barkas
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

5.  Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.

Authors:  M Oshima; T Ashizawa; M S Pollack; M Z Atassi
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

Review 6.  The anatomy of T-cell activation and tolerance.

Authors:  A Mondino; A Khoruts; M K Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

7.  Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.

Authors:  A Wakkach; T Guyon; C Bruand; S Tzartos; S Cohen-Kaminsky; S Berrih-Aknin
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

8.  Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.

Authors:  N Sommer; N Willcox; G C Harcourt; J Newsom-Davis
Journal:  Ann Neurol       Date:  1990-09       Impact factor: 10.422

9.  Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.

Authors:  D B Drachman; C W Angus; R N Adams; J D Michelson; G J Hoffman
Journal:  N Engl J Med       Date:  1978-05-18       Impact factor: 91.245

10.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.

Authors:  J Newsom-Davis; N Willcox; L Calder
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.